SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-000115
Filing Date
2022-02-11
Accepted
2022-02-10 19:49:41
Documents
69
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20211231x10q.htm   iXBRL 10-Q 1116794
2 EX-31.1 tmb-20211231xex31d1.htm EX-31.1 13937
3 EX-31.2 tmb-20211231xex31d2.htm EX-31.2 14213
4 EX-32.1 tmb-20211231xex32d1.htm EX-32.1 10285
5 GRAPHIC tmb-20211231x10q001.jpg GRAPHIC 31956
  Complete submission text file 0001410578-22-000115.txt   5572371

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20211231.xsd EX-101.SCH 37702
7 EX-101.CAL tmb-20211231_cal.xml EX-101.CAL 44490
8 EX-101.DEF tmb-20211231_def.xml EX-101.DEF 130256
9 EX-101.LAB tmb-20211231_lab.xml EX-101.LAB 388067
10 EX-101.PRE tmb-20211231_pre.xml EX-101.PRE 278218
63 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20211231x10q_htm.xml XML 1000086
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 22616098
SIC: 2834 Pharmaceutical Preparations